Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Pre-treatment evaluation between treatment group and waitlist

From: A randomized controlled pilot study of a brief web-based mindfulness training

Measure Treatment M(SD) Waitlist M(SD) t (df 45) SE p d[CI %95]
GSI 53.32 (16.14) 51.21 (10.83) 0.54 3.93 .594 0.16 [-0.42, 0.74]
PSQ 40.06 (16.39) 35.09 (13.40) 1.10 4.54 .261 0.33 [-0.26, 0.92]
FMI 37.04 (5.37) 39.95 (6.46) -1.68 1.73 .100 -0.51 [-1.10, 0.08]
SEK-27 2.70 (0.48) 2.88 (0.56) -1.22 0.15 .230 -037 [-0.96, -0.22]
PANAS neg 1.48 (0.93) 1.17 (0.65) 1.25 0.25 .218 0.38 [0.21, 0.97]
PANAS pos 2.54 (0.537) 2.86 (0.46) -2.03 0.16 .048 -0.62 [-1.22, -0.02]